Trial Profile
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Nov 2021 Results of post-hoc analysis published in the Liver International
- 27 Oct 2009 New trial record